Similar articles

• Conservative treatment of placenta increta with methotrexate.

  Crespo R, Lapresta M, Madani B. Crespo R, et al. Int J Gynaecol Obstet. 2005 Nov;91(2):162-3. doi: 10.1016/j.ijgo.2005.06.028. Epub 2005 Aug 29. Int J Gynaecol Obstet. 2005. PMID: 16126207 No abstract available.
• Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.

  Honnma H, Endo T, Hayashi T, Saito T. Honnma H, et al. Eur J Obstet Gynecol Reprod Biol. 2007 Sep;134(1):131-3. doi: 10.1016/j.ejogrb.2006.07.030. Epub 2006 Sep 7. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16962230 No abstract available.
• Placenta increta: evaluation of radiological investigations and therapeutic options of conservative management.

  Panoskaltsis TA, Ascarelli A, de Souza N, Sims CD, Edmonds KD. Panoskaltsis TA, et al. BJOG. 2000 Jun;107(6):802-6. doi: 10.1111/j.1471-0528.2000.tb13345.x. BJOG. 2000. PMID: 10847240 No abstract available.
• Management of Abnormal Placenta Implantation with Methotrexate: A Review of Published Data.

  Farasatinasab M, Moghaddas A, Dashti-Khadivaki S, Raoofi Z, Nasiripour S. Farasatinasab M, et al. Gynecol Obstet Invest. 2016;81(6):481-496. doi: 10.1159/000447556. Epub 2016 Jul 7. Gynecol Obstet Invest. 2016. PMID: 27384687 Review.
• Surgical management of placenta accreta: to leave or remove the placenta?

  Perez-Delboy A, Wright JD. Perez-Delboy A, et al. BJOG. 2014 Jan;121(2):163-9; discussion 169-70. doi: 10.1111/1471-0528.12524. BJOG. 2014. PMID: 24373590 Review.